|
|
We are concerned that certain inaccurate news accounts published recently may needlessly alarm the population of physicians and patients using ACTIQ® (oral transmucosal fentanyl citrate) [C-II]. Patient health and safety have always been and remain our first priority.
We want to set the record straight about ACTIQ. »
|
|